Table 1 Patient demographics.
From: Comparison of radiomic feature aggregation methods for patients with multiple tumors
Age | |
< 50 | 121 (14.6%) |
50–59 | 199 (23.9%) |
60–69 | 282 (33.9%) |
> 70 | 229 (27.6%) |
Primary cancer site | |
NSCLC | 341 (41.0%) |
Melanoma | 144 (17.3%) |
Breast | 109 (13.1%) |
SCLC | 55 (6.6%) |
Renal | 49 (5.9%) |
GI | 44 (5.3%) |
Other | 89 (10.7%) |
Number of metastases | |
< 5 | 543 (65.3%) |
5–10 | 214 (25.8%) |
11 + | 74 (8.9%) |
Karnofsky performance status* | |
100 | 216 (29.1%) |
90 | 161 (21.7%) |
80 | 160 (21.6%) |
70 | 102 (13.8%) |
60 | 85 (11.5%) |
50 | 13 (1.8%) |
≤40 | 4 (0.5%) |
Presence of extracranial metastases | |
Yes | 608 (73.2%) |
No | 223 (26.8%) |
